Loading…

Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity

Saved in:

Bibliographic Details
Published in:	British journal of haematology 2018-05, Vol.181 (3), p.413-417
Main Authors:	Lohse, Stefan, Loew, Sebastian, Kretschmer, Anna, Jansen, J. H. Marco, Meyer, Saskia, ten Broeke, Toine, Rösner, Thies, Dechant, Michael, Derer, Stefanie, Klausz, Katja, Kellner, Christian, Schwanbeck, Ralf, French, Ruth R., Tipton, Thomas R. W., Cragg, Mark S., Schewe, Denis M., Peipp, Matthias, Leusen, Jeanette H. W., Valerius, Thomas
Format:	Article
Language:	English
Subjects:	ADCC Animals antibody therapy Antibody-Dependent Cell Cytotoxicity - drug effects Antigens, CD20 - immunology Antineoplastic Agents, Immunological - immunology Antineoplastic Agents, Immunological - pharmacology CD20 CD20 antigen CHO Cells Complement System Proteins - immunology Cricetulus Cytotoxicity Hematology Humans IgA antibody Immunoglobulin A Immunoglobulin A - immunology Immunoglobulin A - pharmacology Leukemia, Prolymphocytic, B-Cell - drug therapy Leukemia, Prolymphocytic, B-Cell - immunology Leukemia, Prolymphocytic, B-Cell - pathology Myeloid cells Myeloid Cells - immunology Myeloid Cells - pathology myeloid effector cells
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!